doses equal to or greater than 100 mg/kg/day (dexlansoprazole exposure based on AUC approximately equal to that in pediatric patients one year to two years of age) produced delayed growth, with impairment of weight gain observed as early as postnatal Day 10 (age equivalent to neonatal humans...
Armental, M. (2015, January 26). Teva: FDA Approves Generic Version of AstraZeneca Heartburn Drug. The Wall Street Journal Retrieved fromhttps://www.wsj.com/articles/teva-fda-approves-generic-version-of-astrazeneca-heartburn-drug-1422307907 ...